OAM
BNTX icon

Oppenheimer Asset Management’s BioNTech BNTX Stock Holding History

Oppenheimer Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,349
Closed -$1.72M – 1171
2024
Q2 		$1.72M Buy
21,349
+16
+0.1% +$1.46K 0.02% 572
2024
Q1 		$1.97M Sell
21,333
-1,258
-6% -$121K 0.03% 493
2023
Q4 		$2.38M Buy
+22,591
New +$2.28M 0.03% 465
2022
Q1 		– Sell
-1,541
Closed -$397K – 1203
2021
Q4 		$397K Buy
+1,541
New +$422K 0.01% 1018

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oppenheimer Asset Management's BNTX Position: Q3 2024 in Review

Oppenheimer Asset Management sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 21,349 shares — an estimated $1.72M sold.

Oppenheimer Asset Management first reported a position in BNTX in Q4 2021 and held it in 4 quarters. The position peaked at $2.38M in Q4 2023. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Oppenheimer Asset Management reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Oppenheimer Asset Management sold 21,349 BioNTech shares in Q3 2024, an estimated $1.72M.
  • Oppenheimer Asset Management first reported a position in BioNTech in Q4 2021 and held it in 4 quarters.
  • Oppenheimer Asset Management's BioNTech position peaked at $2.38M in Q4 2023.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Oppenheimer Asset Management's 13F filing for Q3 2024, filed 5 Nov 2024.